ADRIATIC: A Phase III Study with Durvalumab +/- Tremelimumab after concurrent Radiochemotherapy for Patients with SCLC in Stage Limited Disease

F. Griesinger; S. Senan; N. Shire; G. Mak; W. Yao; H. Jiang; M. Thomas

doi:https://doi.org/10.1055/s-0039-3403142

ADRIATIC: A Phase III Study with Durvalumab +/- Tremelimumab after concurrent Radiochemotherapy for Patients with SCLC in Stage Limited Disease

F. Griesinger, S. Senan, N. Shire, G. Mak, W. Yao, H. Jiang, M. Thomas

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S36-S37
Journal	Pneumologie
Volume	74
DOIs	https://doi.org/10.1055/s-0039-3403142
Publication status	Published - Mar 2020

Access to Document

https://doi.org/10.1055/s-0039-3403142

Cite this

@article{85d60305dc694b18908b6306d3f24590,

title = "ADRIATIC: A Phase III Study with Durvalumab +/- Tremelimumab after concurrent Radiochemotherapy for Patients with SCLC in Stage Limited Disease",

author = "F. Griesinger and S. Senan and N. Shire and G. Mak and W. Yao and H. Jiang and M. Thomas",

year = "2020",

month = mar,

doi = "https://doi.org/10.1055/s-0039-3403142",

language = "English",

volume = "74",

pages = "S36--S37",

journal = "Pneumologie",

issn = "0934-8387",

publisher = "Georg Thieme Verlag",

}

TY - JOUR

T1 - ADRIATIC: A Phase III Study with Durvalumab +/- Tremelimumab after concurrent Radiochemotherapy for Patients with SCLC in Stage Limited Disease

AU - Griesinger, F.

AU - Senan, S.

AU - Shire, N.

AU - Mak, G.

AU - Yao, W.

AU - Jiang, H.

AU - Thomas, M.

PY - 2020/3

Y1 - 2020/3

U2 - https://doi.org/10.1055/s-0039-3403142

DO - https://doi.org/10.1055/s-0039-3403142

M3 - Meeting Abstract

SN - 0934-8387

VL - 74

SP - S36-S37

JO - Pneumologie

JF - Pneumologie

ER -